# OnCo record nct06015503 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06015503/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06015503", "NCT06015503" ;
  schema:name "A Phase Ⅱ Study Assessing the Safety and Efficacy of PLB1004 in EGFR ex20ins Mutation Patients With Advanced and Metastatic Non-small Cell Lung Cancer(NSCLC)"@en ;
  schema:alternateName "KANNON"@en ;
  schema:description "A phase 2 trial of PLB1004 in non-small-cell lung cancer, run by Avistone Biotechnology Co., Ltd., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06015503/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06015503> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2023-07-21" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/egfr-mutant-nsclc/> ;
  onco:companies <https://onco.cc/companies/avistone-biotechnology/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct06015503-j-thorac-oncol-2026/> .